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Abstract 
Background: Colon malignancies are one of the most common worldwide. Different 
pro-carcinogenic agents such as polycyclic aromatic hydrocarbons (PAH) and heter-
ocyclic aromatic amines can potentially play a key role in the malignant transfor-
mation of cells by interacting with DNA. The enzyme of the 1
st
 phase of xenobiotic
biotransformation CYP1B1 is involved in the metabolic activation of various carcin-
ogens. The aim of the study: The aim of our study was to investigate the association 
between common SNP rs1056836 CYP1B1 and the risk of CRC in the population of 
Central Russia. Materials and methods: A total of 256 patients with colorectal can-
cer (134 males, 122 females) and 608 age- and sex-matched healthy controls (279 
males, 329 females) were recruited for the study. Genotyping of single nucleotide 
polymorphism L432V (rs1056836) CYP1B1 were done using Taq-Man-based assays. 
Results: Single nucleotide polymorphism rs1056836 (substitution L432V) CYP1B1 
was associated with the increased risk of colorectal cancer in the population of Cen-
tral Russia after adjustment for gender, age: ORadj=1.34; 95%CIadj=1.08–1.66; 
Padj=0.01. Bioinformatic analysis showed the spectrum of transcription factors bind-
ing with low-risk C (L) allele are involved in regulation of differentiation of CD8+ 
alpha-beta T cells (FDR=7.57×10
-3





). Transcription factors binding with high-risk V allele
are not involved in T cell dependent mechanisms of cancer immunoediting. Conclu-
sion: Thus, SNP rs1056836 CYP1B1 is associated with the increased risk of colorec-
tal cancer in the population from Central Russia. 
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Introduction. Colon malignancies are 
one of the most common worldwide [1, 2]. 
Neoplasms with localization in the colon and 
rectum are combined into the general concept 
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of colorectal cancer (CRC). Colorectal cancer 
is generally originate from epithelial cells of 
the intestinal wall and is of multifactorial na-
ture, reflecting the complex interaction of en-
vironmental factors with an individual genetic 
background that significantly causes the risk 
of the disease [3]. 
Known environmental risk factors for 
developing colorectal cancer are the follow-
ing: high fat diet, alcohol, cigarette smoke, 
red meat cooked at high temperature; they are 
sources of high levels of polycyclic aromatic 
hydrocarbons (PAH) and heterocyclic aro-
matic amines. These pro-carcinogenic agents 
can potentially play a key role in the malig-
nant transformation of cells by interacting 
with DNA [4]. The conversion of carcinogen-
ic compounds entering into the body is carried 
out thanks to the xenobiotic biotransformation 
system which is presented in the body with 
the group of genetically determined enzymes. 
The enzyme of the 1
st
 phase of xenobiotic
biotransformation CYP1B1 is encoded by a 
gene CYP1B1 and is involved in the metabol-
ic activation of PAH. CYP1B1 plays an im-
portant role in carcinogenesis as it activates 
various carcinogens and it is usually overex-
pressed in malignant neoplasms. For example, 
CYP1B1 catalyses the formation of dihydro-
diols of specific PAH as well as their subse-
quent oxidation to carcinogenic epoxides of 
dihydrodiol [5]. In humans, the CYP1B1 gene 
includes more than 50 single nucleotide pol-
ymorphisms (SNP), one of the most frequent 
and functionally significant is L432V 
(rs1056836). Associations between rs1056836 
CYP1B1 polymorphism and the risk of colo-
rectal cancer in the population of Central Rus-
sia have not been studied yet. 
The aim of our study was to investigate 
the association between common SNP 
rs1056836 CYP1B1 and the risk of CRC in 
the population from Central Russia. 
Materials and methods. A total of 777 
unrelated Russian individuals from the Kursk 
region was examined; written informed con-
sent was obtained from all participants prior 
to entering the study. The study included 241 
CRC patients (129 males and 112 females) 
who underwent inpatient treatment at the 
Kursk Regional Clinical Oncology Center be-
tween 2013 and 2017 [6,7]. The control group 
included 536 healthy volunteers (246 males 
and 290 females) without a history of chronic 
diseases. The mean age of CRC patients was 
66.89±9.43 years; the mean age of the control 
individuals was 67.56±6.38 years (P=0.10). 
The groups (CRC patients and controls) were 
frequency-matched according to gender (P 
>0.05).  
Patients were included in the group of 
patients after verification of the final diagno-
sis of the disease, confirmed by clinical and 
laboratory-instrumental methods of research 
(histological examination). The study was ap-
proved by the Regional Ethics Committee of 
Kursk State Medical University. All patients 
signed a voluntary informed consent to partic-
ipate in the study. Venous blood samples 
were obtained from all individuals. Genomic 
DNA was isolated from peripheral blood by 
the standard phenol-chloroform extraction 
method. Genotyping of rs1056836 CYP1B1 
polymorphism was performed by real-time 
PCR using allelic discrimination assay with 
TaqMan probes on a CFX96 amplifier (Bio-
Rad, United States). Regenotyping of 10% of 
the studied samples taken randomly and in the 
absence of information on the status of the 
disease showed 100% reproducibility of the 
original results. 
Associations of alleles with the risk of 
CRC were performed using logistic regression 
analysis. To assess association of genotypes 
with the disease, the odds ratio (OR) and 95% 
confidence interval (CI) values calculated for 
the log-additive regression model were used. 
All calculations were performed, adjusted for 
gender, age, and smoking in the SNPStats 
software program, available online 
(https://www.snpstats.net/start.htm). A value 
of P≤0.05 was taken as statistically signifi-
cant. 
To study the regulatory potential of the 
studied SNP, the atSNP online resource was 
used; it estimates binding  affinity of tran-
scription factors (TF) with DNA depending 
on carriage of reference/alternative allele 
(http://atsnp.biostat.wisc.edu). TF was includ-
ed in the analysis only under the condition of 
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a high and very high degree of SNP influence 
on the interaction of TF with DNA, which 
was estimated using a position weight matrix.  
The Gene Ontology tool 
(http://geneontology.org) was used to search 
for gene ontologies related to the biological 
functions of TF associated with the refer-
ence/alternative allele.  
Results and discussion. The genotype 
frequency distribution of the genotypes 
rs1056836 CYP1B1 in both control and CRC 
groups were in Hardy–Weinberg equilibrium 
(P>0.05). The frequency of the V allele in pa-
tients with CRC was higher compared with 
the control group (OR=1.32; 95%CI=1.07–
1.64; P=0.01) (Table 1). A comparative anal-
ysis of genotype frequencies also showed that 
rs1056836 CYP1B1 polymorphism is associ-
ated with an increased risk of CRC (Table).  
Table 







 corOR (95% CI)
2




L/L 170 (31.7%) 66 (27.4%) 
0.01* 
1.34 
(1.08-1.66) V/L 273 (50.9%) 110 (45.6%) 
V/V 93 (17.4%) 65 (27.0%) 





Note: 1 – P is a value with adjustment for gender, age; 2 – Odds ratio and 95% confidence interval; * – Statistically 
significant differences between groups are demonstrated; ! – Indices calculated for the log-additive regression model 
with adjustment for gender, age. 
The atSNP bioinformatic resource 
showed that the allele L creates DNA binding 
sites for 11 transcription factors: ZBTB7B 
(P=0.001), NFY (P=0.001), ZBTB7C 
(P=0.003), PAX5 (P=0.005), GLIS2 (P=0.01), 
RUNX1 (P=0.01), HOXA5 (P=0.02), TBX2 
(P=0.03), ELK1 (P=0.04), RUNX1 (P=0.04), 
AP1 (P=0.05). Allele V creates binding sites 
for 7 transcription factors: MYC (P=0.003), 
LBX2 (P=0.004), NFE2L1::MAFG (P=0.02), 
NFY (P=0.03), EN2 (P=0.04), MYB 
(P=0.04), Nfe2l2 (P=0.05). Subsequent en-
richment analysis of the biological processes 
using the Gene Ontology Database showed 
that TF binding with protective C(L) allele are 
included in the co-regulation of differentiation 





) and activation of CD8+ al-





). Moreover, the carriage of the V allele leads 
to a loss of DNA binding to TFs involved in 
the regulation of CD8+ alpha-beta T cells. 
It is known that cancer immune-editing 
(the process due to which the immune system 
controls tumor growth and forms the tumor 
immunogenicity) is largely determined by T-
cell immunity. Cytotoxic T lymphocytes are 
one of the most important effector mecha-
nisms of antitumor immunity as they are able 
to recognize a tumor through their clonal T 
cell receptors and provide specific destruction 
of tumor cells by the release of lytic compo-
nents and direct intercellular interaction [8]. It 
is remarkable that, cytolytic activity is per-
formed predominantly by CD8+ T-cells [9]. 
All mentioned above presents important evi-
dence of influence of rs1056836 CYP1B1 on 
the formation of antitumor immune defenses.  
At the same time most of conducted ge-
netic and epidemiological studies have been 
focused on other association mechanisms of 
rs1056836 CYP1B1 with colorectal cancer, 
they reflected functioning and enzymatic ac-
tivity of the protein encoded by CYP1B1. 
Taking into account that colorectal cancer is 
connected with various environmental carcin-
ogens influence and CYP1B1 is a key enzyme 
of xenobiotics biotransformation and it is 
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highly expressed in the large intestine, we 
may suppose that rs1056836 CYP1B1 leads to 
excessive activation of intermediate biotrans-
formation products which are highly DNA 
damage reagent [10]. CYP1B1 rs1056836 is 
associated with different substrate specificity 
and catalytic activity of CYP1B1.  It is proved 
that the variant allele 432V of the CYP1B1 
gene determines greater catalytic activity of 4-
hydroxylation than a wild-type enzyme [11], 
it explains the connection of this SNP with 
increased risk of development of colorectal 
cancer. 
The works devoted to investigation of 
V432L (rs1056836) CYP1B1 polymorphism 
involvement for colorectal cancer develop-
ment are few and contradictory. Thus, the in-
vestigations held in the Czech Republic [12] 
and in Spain [13] did not reveal the associa-
tions of rs1056836 CYP1B1 colorectal cancer 
development. Lack of association of 
rs1056836 CYP1B1 with colorectal cancer 
was shown also by two meta-analyzes held in 
2012 [14] and in 2014 [15]. At the same time 
our results are consistent with those of a ma-
jor study held by The Institute of Cancer Re-
search (Great Britain): they revealed the asso-
ciation of rs1056836 CYP1B1 with colorectal 
cancer development [16]. We should also note 
the recent work by Le Morvan et al., which 
was held on tumor cell lines, and it revealed 
higher proliferative and invasive activity of 
tumor cells upon expression of the variant 
form of rs1056836 CYP1B1, and also in vivo. 
Besides, it was found out that resistance to 
antitumor drugs significantly increases under 
the V allele inheritance [17]. 
Conclusion. Thus, our investigation has 
revealed an association of the rs1056836 
CYP1B1 single nucleotide variant with in-
creased risk for colorectal cancer in the popu-
lation in Central Russia. The mechanisms of 
this association may be related to the influ-
ence of rs1056836 on functional effects of 
CYP1B1 which reflect its participation in the 
activation of xenobiotic with procarcinogenic 
effects as well as to the involvement of this 
SNP in the mechanisms of regulation of anti-
tumor T-cell immunity. 
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